Sequenom Is Improving Prenatal Screening, in Steps

There's been a buzz around Sequenom's prenatal diagnostic technology and the anticipated launch next year of a blood based test for Down's syndrome. Although success is far from assured, the development of that assay has done much to resurrect the company's prospects.

More from Archive

More from Medtech Insight